retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Lilly's achieves 16.8% weight loss in trial Triple G Agonists – Retatrutide.

In the HARMONY-2 (efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide) clinical study, patients were randomized to receive either once-weekly albiglutide (30 mg, titrated up to 50 mg if required for glycemic control) or 10 units of insulin glargine once daily

In emergency situations, patients should always be assumed to be non-fasting

Past strategies for addressing drug shortages in the hospital and community settings included stockpiling, rationing, and utilising alternative therapies

Endocrinology 155, 12801290

Its also important to note that the long-term side effects of these drugs are not yet well-studied, Yuan said

Call your doctor right away if you have serious side effects